Respiratory Infections

1. Front Matter

   Pages i-x

   PDF

2. Soluble Urokinase Plasminogen Activator Receptor: An Indicator of Pneumonia Severity in Children

   • A. Wrotek, T. Jackowska, K. Pawlik

   Pages 1-7

3. Detection of Respiratory Tract Pathogens with Molecular Biology Methods

   • A. Wozniak-Kosek, J. Kosek, B. Zielnik-Jurkiewicz

   Pages 9-13

4. Classical Against Molecular-Genetic Methods for Susceptibility Testing of Antituberculotics

   • I. Porvaznik, J. Mokry, I. Solovic

   Pages 15-22

5. Does Customer Information Fulfill MEDDEV Criteria in Cases of Product Problems of In Vitro Diagnostics for Infection Testing?

   • Jürgen Hannig, Rüdiger Siekmeier

   Pages 23-30

6. Sodium and Copeptin Levels in Children with Community Acquired Pneumonia

   • August Wrotek, Teresa Jackowska, Katarzyna Pawlik

   Pages 31-36

7. Etiological Factors Causing Lower Respiratory Tract Infections Isolated from Hospitalized Patients

   • A. Guzek, Z. Rybicki, K. Korzeniewski, K. Mackiewicz, E. Saks, A. Chciałowski et al.

   Pages 37-44

8. Antibiotic Consumption Pattern in the Neonatal Special Care Unit Before and After Implementation of the Hospital’s Antibiotic Policy

   • A. Nitsch-Osuch, D. Kurpas, E. Kuchar, K. Życińska, T. Zielonka, K. Wardyn

   Pages 45-51

9. Respiratory Tract Infections in Children in Primary Healthcare in Poland

   • E. Kuchar, K. Miśkiewicz, L. Szenborn, D. Kurpas

   Pages 53-59

10. Impact of Updated European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome on Clinical Outcome of Preterm Infants

    • S. Smolarova, L. Kocvarova, K. Matasova, M. Zibolen, A. Calkovska

    Pages 61-66

11. Back Matter

    Pages 67-67

    PDF

The successful prophylaxis and treatment of ubiquitous respiratory infections is essential for the enhancement of public health. The chapters provide new insights into the biology of causative pathogens, tackle the epidemiological aspects, and present an update on diagnostics, prevention and therapy of infections. The emerging new pathogens and antibiotic resistance of the old ones are discussed. Novel markers of the severity of community acquired pneumonia, which bears high morbidity and mortality, also are presented.

• Acute illness
• Antibacterial agents
• Antibiotics
• Bacterial strains
• Diagnostics
• Drug resistance
• General practice
• Infection
• Influenza
• Mycobacterium
• Pneumonia
• Prognosis
• Pulmonary ventilation
• Respiratory virus
• Susceptibility
• Tuberculosis

• Institute of Psychology, Opole University, Poland

  Mieczyslaw Pokorski

Policies and ethics